Takara Bio strengthens its IP position on single cell RNA-seq

MOUNTAIN VIEW, Calif., July 18, 2018 /PRNewswire/ — Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce that patent JP6336080B—covering the Smart-seq2 method, developed by Rickard Sandberg and exclusively licensed to TBUSA by the Ludwig Institute—has been awarded by the Japan Patent Office. Additional patents regarding the Smart-seq2 technology... Read more

Merck KGaA, Darmstadt, Germany, Announces Future Insight Prize of up to € 1 Million for Groundbreaking Scientific Work

17 JUL 2018 | DARMSTADT, GERMANY First prize to be awarded 2019 for work on a visionary product to protect humanity from newly emerging viral diseases Merck KGaA, Darmstadt, Germany, committed to “Future Insight Prize” for the next 35 years Announcement made at “Curious2018 – Future Insight” conference premiere Darmstadt, Germany, July 17, 2018 – Merck KGaA,... Read more

Irvine Scientific Introduces Chemically-Defined Natural Killer Cell Expansion Medium for Immunotherapy & Translational Research Applications

Jul 17, 2018 | Posted in Cell Therapy The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells SANTA ANA, California – July 17, 2018: Irvine Scientific, an industry leader in the development and manufacture of cell culture media, today announced the introduction of PRIME-XV® NK Cell CDM— the first commercially available chemically-defined (CDM), animal... Read more

DNA-Based Pathogen Testing Company PathogenDx Raises $3.4 Million in Convertible Note Round

TUCSON, Ariz., July 17, 2018 /PRNewswire/ — PathogenDx Corporation, the innovative provider of DNA-based pathogen testing technology for the cannabis, botanical, food and agriculture industries, announced today the successful completion of a $3.4 million capital raise, completing the company’s convertible note round. The PathogenDx capital raise was co-led by Altitude Investment Management and The Panther Opportunity Fund. Other key funders include CanopyVentures,... Read more

Smiths Detection technology deployed for NATO Summit security

17 Jul 2018 Smiths Detection technology supported the security operations surrounding the NATO Summit in Brussels on 11th/12th July. A range of solutions were deployed by the European Commission Counter-Terrorism Unit and Belgian Federal Police at Brussels Airport and various key locations around the city to detect potential threats from explosives, chemicals and radiation. Three different types... Read more

Introducing the Ultim® Max range: a new suite of high performance SEM-EDS detectors

17 Jul Oxford Instruments, the global leader in microanalysis systems, is proud to announce the most comprehensive range to date of Silicon Drift Detectors (SDD) for Energy Dispersive (EDS) analysis in the Scanning Electron Microscope.  New Ultim® Max 65mm2 and 40mm2 models have been released, to complete the Ultim range and join the 170mm2, 100mm2, and the unique... Read more

Establishment of a Joint Venture to Provide Shared Factory (Smart Factory) Service in Thailand

TOKYO, Japan, July 13, 2018 — Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced that its wholly owned subsidiary, Hitachi High-Technologies (Singapore) Pte. Ltd. (HTS) and Thailand’s largest industrial cities and smart cities developer Amata Corporation Public Company Limited (Amata) have jointly established Hitachi High-Tech Amata Smart Services Co., Ltd. (HTAS) and launched a full-line... Read more

VWR and E&I Cooperative Services Sign Contract to Benefit E&I Members

RADNOR, Pa., July 12, 2018 /PRNewswire/ — VWR, acquired by Avantor in 2017 as a wholly-owned subsidiary and leading global provider of product and service solutions to laboratory and production customers, has been awarded a five-year laboratory supplies and services contract by E&I Cooperative Services (E&I), effective July 1, 2018. E&I is the only member-owned, non-profit purchasing cooperative solely... Read more

NanoView Biosciences Appoints Jerry Williamson as Chief Executive Officer

Company prepares for commercial launch of its innovative products for detection and characterization of Exosomes Boston, MA- NanoView Biosciences, (“NanoView” or the “Company”), an emerging leader in commercializing high value exosome-associated products, today announced that Jerry Williamson has been named as the Company’s new Chief Executive Officer effective July 1, 2018, and continues as a... Read more

Kewaunee Scientific Announces VP Sales & Marketing – Americas Retirement and Appointment of Successor

STATESVILLE, N.C. July 16, 2018 – Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that Dana L. Dahlgren, Kewaunee’s Vice President of Sales and Marketing – Americas, retired after 28 years of service with the Company. Mr. Dahlgren, 62, joined the Company in November 1989 as a Regional Sales Manager and was promoted to Director of... Read more